RASSF1 and neuroblastoma: Detection of RASSF1A-M by ddPCR in plasma of patients with high-risk neuroblastoma clearly showed a significantly poorer event-free survival when hypermethylated RASSF1A exceeded 27,681 copies/mL at diagnosis (32).